AI could help doctors personalize treatment for autoimmune hepatitis
NCT ID NCT07378202
First seen Feb 01, 2026 · Last updated May 21, 2026 · Updated 14 times
Summary
This study uses artificial intelligence to analyze data from 5,000 people with autoimmune hepatitis. The goal is to create computer models that can predict which patients will respond well to standard therapy within 6 to 12 months. By identifying these patterns early, doctors may be able to adjust treatments sooner and improve long-term outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE HEPATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Else Kroener Fresenius Center for Digital Health, Technical University Dresden
Dresden, Germany
-
Hannover Medical School
Hanover, 30625, Germany
Conditions
Explore the condition pages connected to this study.